Buscar resultados de ensayos clínicos
Behcet Syndrome - 48 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Tocilizumab for the Treatment of Behcet's Syndrome Condición: Behcet Syndrome Fecha: 2012-09-19 Intervenciones: Drug: Tocilizumab Intravenous infusions every 4 weeks for 3 doses. |
Completed |
Nombre del estudio: Psychological Symptoms in Patients With Behcet's Disease by SCL90-R Condición: Behcet's Syndrome Fecha: 2008-06-17 |
Active, not recruiting |
Nombre del estudio: A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease Condición: Behcet Syndrome Fecha: 2014-12-02 Intervenciones:
|
Completed |
Nombre del estudio: Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease Condición: Behcet's Syndrome Fecha: 2008-06-17 Intervenciones:
|
Completed |
Nombre del estudio: Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease Condición: Behcet's Syndrome Fecha: 2008-04-20 Intervenciones:
|
Completed |
Nombre del estudio: A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease Condición: Behcet Syndrome Fecha: 2009-03-18 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome Condición: Female Patients With Behcet's Syndrome Fecha: 2012-09-19 Intervenciones: Drug: Abatacept Weekly injections with Abatacept 125 mg over 6 months |
Completed |
Nombre del estudio: Behçet's Disease and Eosinophil Cationic Protein Condición: Behçet's Disease Fecha: 2012-04-24 Intervenciones: Other: eosinophil cationic protein Serum eosinophil cationic protein levels |
Completed |
Nombre del estudio: Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation) Condición: Behcet's Disease Fecha: 2013-07-16 |
Recruiting |
Nombre del estudio: A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease Condición: Behcet Disease Fecha: 2015-06-29 Intervenciones: Drug: Infliximab Participants will receive infliximab 5 milligram per kilogram (mg/kg) infusion at Week |